PDCD1 and rectal cancer: These results align with a recent dedicated MRI-pathology correlation study in MSI-H/dMMR rectal cancer, which reported pseudo-residue and pseudo-progression in 77% and 23% of tumors, respectively, after PD-1 blockade, with patterns not observed after chemoradiation.11